(g) within a reasonable time, provide such information about the Issuer's and the Group's business, assets and financial condition as the Bond Trustee may reasonably request.
(a) not carry out any demerger or other corporate reorganisation involving a split into two or more separate companies or entities if such transaction has a Material Adverse Effect;
(b) not cease to carry on its business, if such cessation would have a Material Adverse Effect, and shall procure that no substantial change is made to the general nature of the business from that carried on at the date o f these Bond Terms and/or as set out in these Bond Terms;
(c) carry on its business in accordance with acknowledged, careful and sound practices in all material aspects and comply in all material respects with all laws and regulations it may be subject to from time to time;
31 (55)
(d) procure to deliver on its own accord the annual audited and quarterly interim unaudited reports of either the Parent or Silk BidCo (on a consolidated basis), which shall be made available on the relevant website (alternatively by sending them to the Bond Trustee for publishing on www.stamdata.no) as soon as they are made available, and not later than 120 calendar days after the end of the financial year and not later than 60 calendar days after the end of the relevant interim period; and
(e) procure that upgrade cost not covered by proceeds from the Bonds are financed with proceeds from new equity of Permitted Subordinated Loans.
14. GENERAL UNDERTAKINGS The Issuer undertakes to (and shall, where applicable, procure that the other Group Companies will) comply with the undertakings set forth in this Clause 14 (General undertakings).
14.1 Authorisations The Issuer shall, and shall procure that each other Group Company will, in all material respects obtain, maintain and comply with the terms of any authorisation, approval, license and consent required for the conduct of its business as carried out at the date of these Bond Terms if a failure to do so would have Material Adverse Effect.
